The groundbreaking rise of Viagra has long been a example of pharmaceutical success, however its future within the broader sector now triggers questions about future yields . Alternative versions are eroding market share, prompting anxieties that investing in companies closely tied to Viagra's previous standing could be a speculative decision , esp